VBI Vaccines Stock Price, News & Analysis (TSE:VBV)

C$5.80 0.05 (0.87 %)
(As of 11/21/2017 07:15 AM ET)
Previous CloseC$5.75
Today's RangeC$5.65 - C$5.86
52-Week RangeC$3.77 - C$8.94
Volume9,340 shs
Average Volume4,536 shs
Market CapitalizationC$290.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65

About VBI Vaccines (TSE:VBV)

VBI Vaccines logoVBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process. The company also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants. In addition, it is developing CMV vaccine program, which is in Phase I clinical trials for the prevention of human cytomegalovirus infection; and for glioblastoma multiforme, which is in preclinical testing stage. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: N/A
  • Symbol: TSE:VBV
  • CUSIP: N/A
  • Web: www.vbivaccines.com
Profitability:
  • Trailing EPS: C($0.91)
  • Net Margins: -2,620.06%
  • Return on Equity: -49.79%
  • Return on Assets: -38.26%
Misc:
  • Outstanding Shares: 63,805,000
 

Frequently Asked Questions for VBI Vaccines (TSE:VBV)

What is VBI Vaccines' stock symbol?

VBI Vaccines trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VBV."

When will VBI Vaccines make its next earnings announcement?

VBI Vaccines is scheduled to release their next quarterly earnings announcement on Friday, March, 23rd 2018. View Earnings Estimates for VBI Vaccines.

Who are some of VBI Vaccines' key competitors?

Who are VBI Vaccines' key executives?

VBI Vaccines' management team includes the folowing people:

  • Steven D. Rubin, Chairman of the Board
  • Curtis A. Lockshin, Chief Executive Officer, Director
  • Athena Kartsaklis, Principal Financial and Accounting Officer, Senior Vice President - Finance, Chief Compliance Officer, Corporate Controller (Age 52)
  • Shayla Forster, Corporate Secretary
  • Dmitry Genkin, Director
  • Kate Inman, Director
  • Adam Logal, Director
  • Ran Nussbaum, Director (Age 44)
  • David S. Rector, Additional Independent Director (Age 68)

How do I buy VBI Vaccines stock?

Shares of VBI Vaccines and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is VBI Vaccines' stock price today?

One share of VBI Vaccines stock can currently be purchased for approximately C$5.80.

How big of a company is VBI Vaccines?

VBI Vaccines has a market capitalization of C$290.28 million.

How can I contact VBI Vaccines?

VBI Vaccines' mailing address is 222 3rd St Ste 2241, CAMBRIDGE, MA 02142-1259, United States. The company can be reached via phone at +1-617-8303031.


MarketBeat Community Rating for VBI Vaccines (TSE VBV)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  10
MarketBeat's community ratings are surveys of what our community members think about VBI Vaccines and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for VBI Vaccines (TSE:VBV)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for VBI Vaccines (TSE:VBV)

Price Target History for VBI Vaccines (TSE:VBV)

Analysts' Ratings History for VBI Vaccines (TSE:VBV)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for VBI Vaccines (TSE:VBV)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for VBI Vaccines (TSE:VBV)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for VBI Vaccines (TSE:VBV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for VBI Vaccines (TSE VBV)

Insider Trades by Quarter for VBI Vaccines (TSE:VBV)

Insider Trades by Quarter for VBI Vaccines (TSE VBV)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2017Francisco Diaz-MitomaInsiderBuy3,000C$3.17C$9,510.00
8/21/2017Jeffrey Royston BaxterDirectorBuy10,000C$3.22C$32,200.00
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for VBI Vaccines (TSE VBV)

Source:
DateHeadline
Insider Buying: VBI Vaccines Inc (VBV) Director Acquires 10,000 Shares of StockInsider Buying: VBI Vaccines Inc (VBV) Director Acquires 10,000 Shares of Stock
www.americanbankingnews.com - August 23 at 8:50 PM

Social Media

Financials

Financials are not available for this stock.

Chart

VBI Vaccines (TSE VBV) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.